First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy

Photo: Good News Network · Original story
A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported that their Phase 1 human trial showed a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe […] The post First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy appeared first on Good News Network.
Read the full story at Good News Network.
Business, jobs and community in one placeJeepney.io is a free community with a marketplace, wallet, jobs and groups.Join Jeepney.io free Browse Jeepney Marketplace →



